PhRMA’s asks regarding special 301, drug pricing and reimbursement

Below are asks from the 2010 PhRMA submission to the USTR Special 301 list on the topic of drug pricing and reimbursement decisions, and described as ‘Market Access Barriers.’ In its assertions, PhRMA attack countries for government price negotiations, making use of reference pricing, the insufficient involvement of pharmaceutical companies in setting government pricing policies and the composition of drug formularies, among other things.

CHINA

Continue Reading

Uncategorized

KEI comments on U.S.T.R. 2010 Special 301

KEI is one of several public health groups working with Sean Flynn on filing comments in the current U.S.T.R. request for comments on the Special 301 process (Federal Register Notice USTR-2010-0003-0129). In addition, KEI filed these comments:

KEI comments on Special 301

18 February 2010

KEI provides the following comments regarding the 2010 Special 301 Review, including but not limited to the Identification of Countries Under Section 182 of the Trade Act of 1974.

Our comments include the following points:

    Continue Reading

1

The baffling WHO EWG analysis of innovation inducement prizes

The World Health Organization (WHO) Executive Board will soon consider the Executive Summary of the Report of the Expert Working Group on Research and Development Financing, a document, formally identified as EB 126/6 Add.1.

In the section of the report on “Funding allocation proposals,” the EWG considers two types of innovation inducement prizes, including

31 (c) milestone prizes; and
31 (d) end-prizes (cash)

Continue Reading

LCA, EFF, and COSLA filed comments regarding the treaty to facilitate access and sharing for people with reading disabilities.

The Library Copyright Alliance (LCA) consists of the American Library Association, the Association of College and Research Libraries and the Association of Research Libraries.

Collectively, the ALA, ACRL and ARL represent over 139,000 libraries in the United States employing approximately 350,000 librarians and other personnel.

Continue Reading

Uncategorized

Intervention of India at MSF workshop at the WTO Public Forum

India delivered the following intervention at MSF’s workshop at the World Trade Organization Public Forum today. The title of the MSF workshop was “Controversy at customs – the detention of medicines in transit: what impact on access to medicines?”

WTO Public Forum ( MSF event)

Controversy at customs – the detention of medicines in transit: what impact on access to medicines?

Wednesday 30 September 2009, 14:15 to 16:15

WTO building, Room A

Continue Reading

Uncategorized
2

KEI Brownbag on Bilski case: Scope of Patentable Subject Matter

Date: September 10, 2009

On September 10, 2009 KEI hosted a brownbag lunch to discuss the scope of patentable subject matter, focusing specifically on the implications for life-science patents of the Supreme Court’s forthcoming review of the Bilski Federal Circuit opinion. This is the first time since 1981 that the US Supreme Court will address the limits of patentable subject matter.

The key U.S. statue on this issue is Section 101 of the patent law:

35 USC 101. Inventions patentable

Continue Reading

Uncategorized